Weave Communications, Inc. · NYSE:WEAV

Weave Communications — Raymond James Institutional Investors Conference 2026

13 slides from Weave Communications's conference presentation, Mar 2, 2026

  1. Slide 1: Raymond James Conference

    Raymond James Conference March 2, 2026 NYSE : WEAV MARCH 2026 1

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement This presentation has been prepared by Weave Communications, Inc. (“Weave”, “we”, “us”, or “our”) for informational purposes only and not for any other purpose. This presentation contains “forward-looking statements” within the Private Securities Litigation Reform Act of 1995 t

  3. Slide 3: A better healthcare experience.

    A better healthcare experience. Every practice. Every patient. Every interaction. Who we are Leading vertical platform that delivers $239M AI-powered patient engagement and FY’25 Total Revenue payment solutions for small and 17% YoY Growth medium-sized healthcare practices. What we do Help practices

  4. Slide 4: Running a modern healthcare practice is complicated

    Running a modern healthcare practice is complicated Delivering consistent growth Accelerating revenue cycles Elevating patient experiences Optimizing operations MARCH 2026 4

  5. Slide 5: Weave is a unified platform purpose built for SMB healthcare practices.

    Weave is a unified platform purpose built for SMB healthcare practices. Reviews. Phones. Texting. Reminders. Payments. Analytics. AI. MARCH 2026 5

  6. Slide 6: AI Receptionist: a trusted team member

    AI Receptionist: a trusted team Patient member AI Agent Available 24/7 The AI-powered future is designed to help healthcare practices better serve people. Practice Staff Available 8—5PM Patient + Practice Barriers Valuable Patient Interactions MARCH 2026 6

  7. Slide 7: Weave TAM

    Weave TAM International $22B Future TAM Opportunity Target international healthcare SMBs. Target Markets 1,4 (DOVM) Further Expanding TAM Significant opportunity to expand TAM within medical verticals beyond $10B DOV Weave’s current focus markets. + All Medical (US) 3 Growing Opportunity in Current

  8. Slide 8: As we create more value, our opportunity grows

    As we create more value, our opportunity grows MARCH 2026 8

  9. Slide 9: Topline Revenue Growth at Scale ($M)

    Topline Revenue Growth 17% at Scale ($M) $63.4 $61.3 $58.5 Q4—2025 $55.8 $54.2 17% $52.4 YoY Revenue Growth $50.6 $47.2 $45.7 Q4—23 Q1—24 Q2—24 Q3—24 Q4—24 Q1—25 Q2—25 Q3—25 Q4—25 MARCH 2026 9

  10. Slide 10: Strong Progress on Gross Margin

    Strong Progress on Gross Margin +70 basis points 73.3% 72.6% 73.0% 72.5% 72.1% 72.3% 72.0% 72.1% 72.3% 72.7% 71.6% 71.7% 71.9% 71.4% 70.4% 69.9% 69.7% 69.1% Q4—23 Q1—24 Q2—24 Q3—24 Q4—24 Q1—25 Q2—25 Q3—25 Q4—25 GAAP GM% Non-GAAP GM% 58% Non-GAAP Gross Margin at IPO (2021) MARCH 2026 10

  11. Slide 11: Improving Cash Flows ($M)

    Improving Cash Flows ($M) $17.5 $14.1 $12.9 $10.2 $10.4 $6.5 $12.8 $15.9 $20.4 $30.2 2021 2022 2023 2024 2025 Free Cash Flow Cash from Operations MARCH 2026 11

  12. Slide 12: Investor highlights

    Investor highlights AI Powered Multiple New Resilient Efficiently Scaling Communication & Vectors of Growth Customer Base the Business Payments Platform Expanding through specialty SMB healthcare practices Effectively balancing growth medical verticals, payments, have proven resilient despite while

  13. Slide 13: MARCH 2026

    MARCH 2026 13

Weave Communications — Raymond James Institutional Investors Conference 2026 on 6ix